Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan-Reference-Cited by-同舟云学术

Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan

Published:2017-04-07 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Takura Tomoyuki,Takei Takashi,Nitta Kosaku

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep46036.pdf

Reference23 articles.

1. Yokoyama, H., Taguchi, T., Sugiyama, H. & Sato, H. Membranous nephropathy in Japan: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin. Exp. Nephrol. 16, 557–563 (2012).

2. Benz, K., Dötsch, J., Rascher, W. & Stachel, D. Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr. Nephrol. 19, 794–797 (2004).

3. Gilbert, R. D., Hulse, E. & Rigden, S. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr. Nephrol. 21, 1698–1700 (2006).

4. Dötsch, J., Müller-Wiefel, D. E. & Kemper, M. J. Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible? Pediatr. Nephrol. 23, 3–7 (2008).

5. François, H., Daugas, E., Bensman, A. & Ronco P. Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am. J. Kidney Dis. 9, 158–161 (2007).

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Japanese clinical practice patterns of rituximab treatment for minimal change disease in adults 2021: A web-based questionnaire survey of certified nephrologists;PLOS ONE;2024-03-29

2. Immunosuppressive agents for frequently relapsing/steroid-dependent nephrotic syndrome in children: a systematic review and network meta-analysis;Frontiers in Immunology;2024-02-23

3. Optimal assessment share structured of Pharmacoeconomics for medical drugs according to minimax criterion;PHARM PRACT-GRANADA;2024

4. Immunosuppressive Agent Options for Primary Nephrotic Syndrome: A Review of Network Meta-Analyses and Cost-Effectiveness Analysis;Medicina;2023-03-17

5. Socio-Economic Considerations of Universal Health Coverage: Focus on the Concept of Health Care Value and Medical Treatment Price;Health Insurance;2022-10-19